DCF — LAS PALMAS MEDICAL CENTER
Enterprise Value: $449.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$449.1M
Enterprise Value
$114.3M
PV of Cash Flows
$334.8M
PV of Terminal Value
$539.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $725.9M | $61.7M | 9.0% | $20.1M | $18.3M |
| Year 2 | $747.6M | $71.0M | 10.0% | $26.3M | $21.7M |
| Year 3 | $770.1M | $80.9M | 11.0% | $32.9M | $24.7M |
| Year 4 | $793.2M | $87.2M | 11.0% | $36.8M | $25.1M |
| Year 5 | $817.0M | $91.9M | 11.0% | $39.5M | $24.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $449.1M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$704.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000034056515
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5